Orbicularis oris, mentalis, depressor anguli oris

Published on 26/02/2015 by admin

Filed under Dermatology

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 3259 times

18 Orbicularis oris, mentalis, depressor anguli oris

Introduction

Botulinum toxin (BoNT) chemodenervation has revolutionized cosmetic surgery. Botulinum toxin treatments complement, and in some cases preclude, traditional invasive surgical procedures. Chemodenervation with BoNT is the cornerstone of minimally invasive upper facial rejuvenation. The safety and efficacy of BoNT in the upper face have been extensively documented. However, BoNT use in the lower face is less well established in well-designed clinical trials.

In the lower face, treatment strategies are traditionally focused on volume restoration; however, controlling hypermobility is also essential. Botulinum toxin is used as monotherapy or as an adjunct to other procedures in lower face rejuvenation. Treatment options include dermal fillers, chemical peels, laser resurfacing, non-invasive tightening modalities, and facelifts (with or without chin / pre-jowl implants) (Table 18.1). Although rhytidectomy can reduce the nasolabial and labiomandibular folds, this procedure cannot enhance the lip region owing to its anatomy. The perioral tissues include supportive ligaments that must be preserved, and there is a high risk of motor innervation injury affecting the perioral area through a facelift. This is due to the buccal and marginal mandibular branches of the facial nerve, which course superficially, ramify extensively, and are challenging to identify. Motor innervation injury leads to muscle weakness. A combination treatment with BoNT and fillers in the lower face has emerged as the gold standard because it addresses a broader spectrum of facial aging changes, without the need for surgery.

This chapter aims to address the use of BoNT in the orbicularis oris, mentalis, and depressor anguli oris (DAO) muscles, as they directly affect the appearance of the perioral and chin regions.

Anatomy

The perioral region, also called the lip unit, is one of the facial cosmetic units. It extends from the base of the nose (subnasal) superiorly to the nasolabial folds laterally, and to the labiomental crease inferiorly. The free edges of the vermilion borders subdivide this region into the upper lip and lower lip. Below the labiomental crease is another facial unit, the chin.

The upper lip is subdivided into the cutaneous upper lip, the vermilion upper lip, and the philtrum. The lower lip is subdivided into the cutaneous lower lip and the vermilion lower lip.

The musculature of the perioral and chin area is complex and includes the orbicularis oris, risorius, DAO, zygomaticus major, zygomaticus minor, levator anguli oris, levator labii superioris, levator labii superioris alaeque nasi (LLSAN), depressor labii inferioris, mentalis, and the platysma (Fig. 18.1).

The orbicularis oris muscle origins are in the deep surface of the perioral skin, the angle of the mouth, superiorly the median plane of the maxilla, and inferiorly the mandible. This muscle inserts into the mucous membrane of lips. It is innervated by the buccal and mandibular branches of the facial nerve. Its tonus closes the rima oris; its phasic contraction compresses and protrudes the lips, aiding mastication, expression, phonation, and the actions of whistling, sucking, and kissing. Additionally, when blowing this muscle has a role resisting distension. The orbicularis oris muscle is necessary for correct speech and allows for enunciation of the letters F, M, O, and P.

The mentalis muscle originates in the body of the mandible and inserts into the orbicularis oris muscle and the skin of the chin. It elevates and protrudes the lower lip, is important for drinking, and elevates the skin of the chin when showing doubt. The mentalis is innervated by the mandibular branch of the facial nerve.

The depressor anguli oris is shaped like a triangle with the vertex located at the angle of the mouth. DAO arises from the oblique line on the anterior mandible. Its fibers blend with the orbicularis oris and are inserted into the corner of mouth. The marginal mandibular branch of the facial nerve innervates this muscle. Its main action is pulling the angle of the mouth inferiorly and laterally.

Perioral and chin aging

Aging of the perioral and chin regions is characterized by radial perioral rhytides (so called smokers’ lines or lipstick lines), decrease in vermilion fullness, inversion of the vermilion, downward turn of the oral commissures, lengthened appearance of the cutaneous portion of the upper lip, pre-jowl notch or sulcus, and chin dimpling. Additionally prominence of the labiomandibular (marionette lines), labiomental, and nasolabial folds can occur (Fig. 18.2A,B).

The pathophysiology of the aging perioral and chin regions is multifactorial, and culminates in the aforementioned aesthetically undesirable appearance. Extrinsic factors, including smoking and sun exposure, can potentiate intrinsic factors. An article published in 1965 by Gonzalez-Uloa & Flores, perhaps the first comprehensive study of facial aging elements, described the decreased thickness and elasticity of skin, decreased adherence between the skin and subcutaneous tissue, sagging of the soft tissues, absorption of fat, resorption of the craniofacial skeleton, and weakening of the muscles.

The paradigm of muscular involvement in the aging face has shifted. It was thought that muscle weakness and laxity caused downward displacement of soft tissue, whereas current theories implicate persistent contraction and increased resting tone in the muscle’s role in facial aging. Repetitive contractions wrinkle the skin in the same way the act of folding and unfolding a paper eventually causes a crease. The increased resting tone exerts constant pressure on the underlying bone, favoring its erosion and posterior remodeling, and projects underlying fat anteriorly. This forms the rationale for BoNT in facial rejuvenation and explains its excellent results when used consistently.

The marionette lines are a consequence of facial aging and form as curvilinear wrinkles extending downward from the oral commissures to the jawline. The etiology of marionette lines is unclear, but they are probably related to DAO hyperactivity, the effects of gravity, mandible and maxillary bone resorption, and fat absorption.

A prominent mentalis muscle can accentuate the horizontal labiomental crease, or produce a cobblestone appearance on the chin. Both effects are accentuated with volume loss.

The labiomental fold is a horizontal fold located between the lower lip and the chin (see Fig. 18.2A,B). It is produced by the depressor anguli oris and the mandibular ligament. The nasolabial fold will be addressed in another chapter.

The pre-jowl sulcus develops with aging as an indentation of the external inferior margin of the jawline between the chin and the jowl, anterior to the marionette line. This notching increases with aging due to atrophy of the soft tissues and bone resorption.

The repetitive muscular actions of the orbicularis oris and volume loss contribute to the radial perioral rhytides.

Rejuvenation

Patient selection for botulinum toxin perioral and chin rejuvenation

Patients are encouraged to verbalize their concerns about their face and their expectations of any intervention. A handheld mirror is indispensible during the consultation. If the patient has realistic expectations and the physician feels that these expectations can be met with an acceptable safety profile, the likelihood of success is maximized.

Botulinum toxin injections are extremely safe, but patients who require precise enunciation and / or tight control of their lips such as singers, musicians, and public speakers are not good candidates for lower face and more specifically perioral rejuvenation with BoNT.

After understanding the patient’s wishes, the physician must choose which approaches are most effective and safe (see Table 18.1). For the lower face, usually a combination of approaches is necessary. Patients whose principal concern is not volume loss, but the end results of muscle hyperactivity, can benefit from BoNT as monotherapy (Table 18.2).

Table 18.2 Botulinum toxin as monotherapy

Muscle target Patient characteristics
Orbicularis oris Radial perioral rhytides
Depressor anguli oris Oral commissure turned downward without much volume loss
Mentalis Dimpling chin

Recently, Carruthers et al have shown that the combination treatment of BoNT and fillers is safe, more effective and longer lasting than either treatment alone.

Botulinum toxin and fillers can be used concomitantly to enhance radial perioral rhytides, the downward turn of the oral commissures, the lengthened appearance of the cutaneous upper lip, the pre-jowl sulcus, and chin dimpling. Additional indications include reduction of labiomandibular (marionette lines), labiomental, and nasolabial folds.

Dosage and injection technique

Prior to treatment, a topical anesthesia is applied to the target region. The authors use 4% lidocaine.

When BoNT and fillers are used in the same session, the authors prefer to administer fillers first.

Before injection the area is cleaned with an alcohol pad and the patient is asked to repeatedly contract and relax the target muscles, helping to aid in the visibility of the targets.

The amount of units below refers to Botox®.

Further reading

Carruthers A, Carruthers J, Monheit GD, et al. Multicenter, randomized, parallel-group study of the safety and effectiveness of onabotulinumtoxinA and hyaluronic acid dermal fillers (24-mg/ml smooth, cohesive gel) alone and in combination for lower facial rejuvenation. Dermatologic Surgery. 2010;36:2121–2134.

Carruthers A, Carruthers J, Monheit GD, et al. Multicenter, randomized, parallel-group study of the safety and effectiveness of onabotulinumtoxinA and hyaluronic acid dermal fillers (24-mg/ml smooth, cohesive gel) alone and in combination for lower facial rejuvenation: Satisfaction and Patient-Report Outcomes. Dermatologic Surgery. 2010;36:2135–2154.

Carruthers JDA, Glogau RG, Blitzer A. Advances in facial rejuvenation: botulinum toxin type A, hyaluronic acid dermal fillers, and combination therapies – consensus recommendations. Plastic and Reconstructive Surgery. 2008;121(5S):S5–S30.

Fitzgerald R, Graivier MH, Kane M, et al. Update on facial aging. Aesthetic Surgery. 2010;30(suppl):S11–S24.

Gonzales-Ulloa M, Flores ES. Senility of the face: basic study to understand its causes and effects. Plastic and Reconstructive Surgery. 1965;36:239–246.

Le Louarn C, Buthiau D, Buis J. Structural aging: the facial recurve concept. Aesthetic Plastic Surgery. 2007;31(3):213–218.

Semchyshyn N, Sengelmann RD. Botulinum toxin A treatment of perioral rhytides. Dermatologic Surgery. 2003;29(5):490–495.

Vleggaar D, Fitzgerald R. Dermatological implications of skeletal aging: a focus on supraperiosteal volumization for perioral rejuvenation. Journal of Drugs in Dermatology. 2008;7(3):209–220.